Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Boeckel, Jes Niels ^a,b,c   Oppermann, Jana ^a   Anadol, Remzi ^a   Fichtlscherer, Stephan ^a   Zeiher, Andreas M ^a,c   Keller, Till ^a,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Center for Molecular Medicine   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; GLYCOPEPTIDE; TROPONIN T;

AGED; AORTA; BIOLOGICAL MODEL; BLOOD; CARDIAC MUSCLE; COHORT ANALYSIS; COMPLICATION; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS); SMOKING;

AGED; AORTA; BIOMARKERS; CARDIAC CATHETERIZATION; COHORT STUDIES; CORONARY CIRCULATION; FEMALE; GLYCOPEPTIDES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIUM; OBESITY; SMOKING; TROPONIN T;

EID: 84958576378     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20812     Document Type: Article

References (26)

1. Tsutamoto, T. et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96, 509-16 (1997).
2. Morgenthaler, N. G., Struck, J., Alonso, C. & Bergmann, A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112-9 (2006).
3. Czaczkes, J. W., Kleeman, C. R. & Koenig, M. Physiologic studies of antidiuretic hormone by its direct measurement in human plasma. J. Clin. Invest. 43, 1625-40 (1964).
4. Yalta, K. et al. Copeptin (C-terminal provasopressin): a promising marker of arrhythmogenesis in arrhythmia prone subjects? Int. J. Cardiol. 148, 105 (2011).
5. Stoiser, B. et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur. J. Clin. Invest. 36, 771-8 (2006).
6. Maisel, A. et al. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ. Heart Fail. 4, 613-20 (2011).
7. Bar-Shalom, D. et al. Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients. Diab. Vasc. Dis. Res. 11, 448-50 (2014).
8. Velho, G. et al. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 36, 3639-3645 (2013).
9. Seligman, R., Papassotiriou, J., Morgenthaler, N. G., Meisner, M. & Teixeira, P. J. Z. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit. Care 12, R11 (2008).
10. Sang, G. et al. Plasma copeptin levels are associated with prognosis of severe acute pancreatitis. Peptides 51, 4-8 (2014).
11. Isman, F. K. et al. Copeptin is a predictive biomarker of severity in acute pancreatitis. Am J Emerg Med. (2013). doi: 10.1016/j. ajem.2012.12.016
12. Katan, M. & Christ-Crain, M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med. Wkly. Off. J. Swiss Soc. Infect. Dis. Swiss Soc. Intern. Med. Swiss Soc. Pneumol. 140, 1-6 (2010).
13. Zhang, Q., Dong, G., Zhao, X., Wang, M. & Li, C.-S. Prognostic significance of hypothalamic-pituitary-adrenal axis hormones in early sepsis: a study performed in the emergency department. Intensive Care Med. 40, 1499-508 (2014).
14. Reichlin, T. et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J. Am. Coll. Cardiol. 54, 60-8 (2009).
15. Maisel, A. et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the Chopin trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J. Am. Coll. Cardiol. 62, 150-60 (2013).
16. Karakas, M. et al. Copeptin does not add diagnostic information to high-sensitivity troponint in low- to intermediate-risk patients with acute chest pain: Results from the Rule Out Myocardial Infarction by Computed Tomography (ROMICAT) study. Clin. Chem. 57, 1137-1145 (2011).
17. Keller, T. et al. Copeptin improves early diagnosis of acute myocardial infarction. J. Am. Coll. Cardiol. 55, 2096-106 (2010).
18. Arima, H. & Aguilera, G. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors. J. Neuroendocrinol. 12, 833-42 (2000).
19. Hupf, H., Grimm, D., Riegger, G. A. & Schunkert, H. Evidence for a vasopressin system in the rat heart. Circ. Res. 84, 365-70 (1999).
20. De Rosa, S. et al. Transcoronary concentration gradients of circulating micro RNAs. Circulation 124, 1936-44 (2011).
21. Nickel, C. H., Bingisser, R. & Morgenthaler, N. G. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med. 10, 7 (2012).
22. Raskovalova, T. et al. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur. Hear. journal. Acute Cardiovasc. care 3, 18-27 (2014).
23. Lipinski, M. J. et al. A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am. J. Cardiol. 113, 1581-91 (2014).
24. Bhandari, S. S. et al. Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin. Sci. (Lond). 116, 257-63 (2009).
25. Giavarina, D. et al. Copeptin and high sensitive troponin for a rapid rule out of acute myocardial infarction? Clin. Lab. 57, 725-30 (2011).
26. Liebetrau, C. et al. Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin. Chem. 59, 566-9 (2013).